Your institution may have access to this item. Find your institution then sign in to continue.
Title
News Update.
Abstract
Reports global developments related to clinical trials as of March 2002. Approval of Swedish Medical Products Agency for the sale of Nascobal gel; Decision of the U.S. Food and Drug Administration to approve the drug, Gleevec by Novartis; Closure of the SU5416 clinical trial program for colorectal cancer by Pharmacia Corporation.